Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Asthma

Free Subscription Articles published in Respir Res Retrieve available abstracts of 116 articles: HTML format

Single Articles

July 2026
1. PAPAVASSILIOU KA, Gogou VA, Papavassiliou AG
   Depemokimab: toward biannual biologic therapy for severe eosinophilic asthma.
   Respir Res. 2026;27:276.
   PubMed     Abstract available
   
   
   June 2026
2. HU M, Chen Y, Huang H, Zhuo J, et al
   H3K18 lactylation promotes allergic airway inflammation in asthma via a CSF1/CSF1R/MAPK autocrine axis.
   Respir Res. 2026 Jun 23. doi: 10.1186/s12931-026-03781.
   PubMed     Abstract available
   
   
   
3. KUANG L, Shu P
   Commenting on "a randomized trial of continuous positive airway pressure for the asthma of obesity" by Anne E. Dixon and colleagues.
   Respir Res. 2026;27:242.
   PubMed    
   
   
   
4. YAN C, Jia X, Ren X, Chen Y, et al
   Mycoplasma pneumoniae infection impairs asthma control in pediatric patients and exacerbates allergic airway inflammation.
   Respir Res. 2026 Jun 11. doi: 10.1186/s12931-026-03755.
   PubMed     Abstract available
   
   
   May 2026
5. LEILY M, Mistry H, Zhang H, Larsson M, et al
   Clinical phenotypes of difficult-to-treat and mild asthma defined by cluster analysis.
   Respir Res. 2026 May 29. doi: 10.1186/s12931-026-03740.
   PubMed     Abstract available
   
   
   
6. HAJMOHAMMADI H, Pfeffer PE, Mudway IS, Griffiths CJ, et al
   Asthma exacerbation risk after short-term air pollution exposure varies by age, sex, severity, and eosinophil count: East London cohort study.
   Respir Res. 2026;27:213.
   PubMed     Abstract available
   
   
   
7. LEE HW, Pyung YJ, Oh S, Lee JK, et al
   Plasma metabolomic signatures associated with inhaled corticosteroid requirements in clinically stable asthma: a prospective cross-sectional study.
   Respir Res. 2026 May 26. doi: 10.1186/s12931-026-03737.
   PubMed     Abstract available
   
   
   
8. JIANG L, Li H, Bao W, Zhang A, et al
   Qingre Runzao oral liquid and its key compound ophiopogonin D inhibit CXCL9 and block CXCL9/CXCR3 axis to ameliorate asthma by suppressing RAS/ERK pathway.
   Respir Res. 2026 May 21. doi: 10.1186/s12931-026-03723.
   PubMed     Abstract available
   
   
   
9. JOHANSSON MW, Esnault S, Floerke HL, Zhang J, et al
   Increased potential for atherogenic changes in asthma: evidence from transcriptomic studies of arterial endothelial cells.
   Respir Res. 2026 May 12. doi: 10.1186/s12931-026-03709.
   PubMed     Abstract available
   
   
   
10. OHRNEMAN H, Malinovschi A, Cai GH, Svartengren M, et al
    Aerosol deposition in the lung as a biomarker in asthma and chronic obstruction.
    Respir Res. 2026 May 11. doi: 10.1186/s12931-026-03706.
    PubMed     Abstract available
    
    
    April 2026
11. MEI S, Zhu L, Zhang K, Thakur A, et al
    Fungal exposure exacerbates allergen-driven asthma in a two-hit mouse model.
    Respir Res. 2026 Apr 28. doi: 10.1186/s12931-026-03684.
    PubMed    
    
    
    
12. HAYASHI Y, Tanabe N, Sato A, Hirano T, et al
    Unsupervised comprehensive CT imaging clusters reveal distinct morphological phenotypes in asthma: insights from two prospective cohorts.
    Respir Res. 2026 Apr 27. doi: 10.1186/s12931-026-03691.
    PubMed    
    
    
    
13. NIU W, Huang J, Hu Y, Tang G, et al
    Short-term effects of air pollutants on asthma hospitalizations in a megacity in North China (2016-2021): a time-series study.
    Respir Res. 2026 Apr 14. doi: 10.1186/s12931-026-03620.
    PubMed    
    
    
    
14. HUGO T, Harper AR, Leander J, Gardiner P, et al
    Elarekibep, an inhaled anti-IL-4 receptor alpha Anticalin, in moderate-to-severe asthma: a randomized, placebo-controlled phase 2a study (APATURA).
    Respir Res. 2026 Apr 14. doi: 10.1186/s12931-026-03613.
    PubMed    
    
    
    
15. FISCHER BC, Drick N, Liu B, Riemann L, et al
    B cell activating factor (BAFF) levels are associated with failed remission after 12 months of treatment with benralizumab and mepolizumab in severe asthma.
    Respir Res. 2026 Apr 2. doi: 10.1186/s12931-026-03500.
    PubMed    
    
    
    March 2026
16. KO FWS, Chan KKP, Ng TCC, Lo RLP, et al
    A 3-year prospective study to assess clinical characteristics and risk factors for exacerbations in patients with asthma-COPD overlap based on the GINA guideline compared with patients with asthma and COPD.
    Respir Res. 2026 Mar 29. doi: 10.1186/s12931-026-03643.
    PubMed    
    
    
    
17. ZHANG M, Liu Q, Ju L, Zheng Y, et al
    Multi-omics integration identifies associations between large high-density lipoprotein and lung function, asthma, and COPD: evidence from genetic and population-based analyses.
    Respir Res. 2026 Mar 6. doi: 10.1186/s12931-026-03562.
    PubMed    
    
    
    February 2026
18. GARCIA-RIVERO JL, Hannaoui Anaaoui A, Pallares-Sanmartin A, Blanco-Aparicio M, et al
    Multidomain clinical and biological remission with tezepelumab in severe asthma: a 12-month multicentre real-world study.
    Respir Res. 2026 Feb 27. doi: 10.1186/s12931-026-03597.
    PubMed    
    
    
    
19. CHEN Z, Cai J, Wang S, Yu W, et al
    GPX4 alleviates airway inflammation by suppressing 5-LO expression and regulating ferroptosis.
    Respir Res. 2026;27:139.
    PubMed     Abstract available
    
    
    
20. CHEN Y, Shen Y, Shen H, Liu Z, et al
    GLP-1RAs: antidiabetic drug crossover-new hope for chronic inflammatory airway diseases.
    Respir Res. 2026;27:144.
    PubMed     Abstract available
    
    
    
21. ZHANG S, Lin J
    The circadian clock component PER2 deficiency aggravates airway epithelial remodeling through Wnt/beta-catenin signaling pathway.
    Respir Res. 2026;27:131.
    PubMed     Abstract available
    
    
    
22. DEVILLIERS MA, Saber Cherif L, Brisebarre A, Chouquet R, et al
    Identification and validation of cilia-associated molecular candidates deregulated in severe asthma.
    Respir Res. 2026 Feb 9. doi: 10.1186/s12931-026-03548.
    PubMed    
    
    
    
23. XIAO Z, Shi Y, Zhao D, Wang Y, et al
    Triggering mechanisms of acute thunderstorm asthma: epithelial barrier disruption and immune dysregulation.
    Respir Res. 2026 Feb 7. doi: 10.1186/s12931-026-03532.
    PubMed     Abstract available
    
    
    
24. BOURDIN A, Canonica GW, Virchow JC, Borsos K, et al
    Comparative effectiveness of biologics in lung function improvement among patients with severe asthma: a real-world study.
    Respir Res. 2026 Feb 4. doi: 10.1186/s12931-026-03515.
    PubMed    
    
    
    January 2026
25. YAO L, Yuan X, Sun P, Fu H, et al
    Desmoglein-2 dysregulation impairs epithelial barrier integrity in eosinophilic asthma.
    Respir Res. 2026 Jan 21. doi: 10.1186/s12931-026-03510.
    PubMed    
    
    
    
26. AEGERTER H, Brightling CE, Dunican EM, Lambrecht BN, et al
    Effectiveness of biologics for reducing occlusive mucus plugs in patients with severe asthma: a systematic review.
    Respir Res. 2026 Jan 21. doi: 10.1186/s12931-026-03501.
    PubMed     Abstract available
    
    
    
27. WANG Y, Xu C, Zeng R, Liu X, et al
    CCN1 drives asthmatic airway remodeling through amplification of TGF-beta1/Smad3 signaling.
    Respir Res. 2026 Jan 20. doi: 10.1186/s12931-026-03506.
    PubMed    
    
    
    
28. LASSER C, Ax E, Weidner J, Winslow S, et al
    The involvement of Th17 inflammation and miR-363-3p in airway epithelial barrier dysfunction.
    Respir Res. 2026;27:30.
    PubMed     Abstract available
    
    
    
29. CARELLI M, Miotti J, Zanolin ME, Bilo MB, et al
    Mediterranean diet and asthma in adults: a multicentre case-control study in a general population sample.
    Respir Res. 2026 Jan 13. doi: 10.1186/s12931-025-03484.
    PubMed    
    
    
    
30. LI X, Zhang J, Feng Y, Zhou Q, et al
    Modulation of the NF-kappaB signaling pathway by the combined strategy of tocilizumab and dexamethasone for asthma therapy.
    Respir Res. 2026 Jan 8. doi: 10.1186/s12931-025-03458.
    PubMed     Abstract available
    
    
    
31. PANETTIERI RA JR, Mohan A, Lugogo NL, Ledford DK, et al
    Outcomes after biologic initiation among patients with severe asthma and normal lung function in the CHRONICLE study.
    Respir Res. 2026;27:5.
    PubMed     Abstract available
    
    
    
32. SHARMA R, Kelly RS, Mendez K, Chen Q, et al
    Differences in microRNA levels across metabo-endotypes reveal novel insights into asthma heterogeneity.
    Respir Res. 2026 Jan 7. doi: 10.1186/s12931-025-03452.
    PubMed    
    
    
    
33. YANG Q, Wang W, Zhu G, Xun H, et al
    GLCCI1 alleviates airway remodeling in asthmatic mice by inhibiting ZEB1-mediated epithelial-mesenchymal transition.
    Respir Res. 2026 Jan 7. doi: 10.1186/s12931-025-03476.
    PubMed    
    
    
    December 2025
34. PIPARIA S, Kho AT, Desai B, Wong R, et al
    A principal component analysis-based endophenotype definition for change in lung function and inhaled corticosteroid treatment response in childhood asthma.
    Respir Res. 2025;26:351.
    PubMed     Abstract available
    
    
    
35. LEE SE, Kim BK, Kang N, Lee Y, et al
    Asthma remission and its predictors in severe asthma: real-world study from the Korean severe asthma registry.
    Respir Res. 2025 Dec 27. doi: 10.1186/s12931-025-03451.
    PubMed     Abstract available
    
    
    
36. WANG K, Wu R, Fan M, Jia R, et al
    CPA3 drives the development of asthma by promoting the activation of the JAK/STAT6 pathway.
    Respir Res. 2025 Dec 23. doi: 10.1186/s12931-025-03456.
    PubMed    
    
    
    
37. ZHANG H, Rao Z, Liu X, Shu Y, et al
    USP18 confers protection against allergic asthma by suppressing CCL8 production in alveolar type II epithelial cells.
    Respir Res. 2025 Dec 8. doi: 10.1186/s12931-025-03433.
    PubMed     Abstract available
    
    
    November 2025
38. TAO X, Xu X, Jiang X, Chen M, et al
    Susceptibility to childhood asthma modified by the interactive effects of polycyclic aromatic hydrocarbons exposure and genetic polymorphisms of the aryl hydrocarbon receptor signaling pathway: functional analysis based on lipid metabolism.
    Respir Res. 2025 Nov 28. doi: 10.1186/s12931-025-03428.
    PubMed     Abstract available
    
    
    
39. DIXON AE, Garrow OJ, Duchene B, Martin F, et al
    A randomized trial of continuous positive airway pressure for the asthma of obesity.
    Respir Res. 2025;26:314.
    PubMed    
    
    
    
40. ABUJABAL R, Alanta TM, Alhamidi RS, Altaie AM, et al
    IL-5 signaling in asthmatic derived fibroblasts exacerbates airway remodeling through ECM dysregulation and apoptosis resistance.
    Respir Res. 2025;26:307.
    PubMed     Abstract available
    
    
    
41. MARCON A, Martinelli L, Bansal AT, Berret E, et al
    Use of long-acting muscarinic antagonists for severe asthma: insights from clinicians in the SHARP network.
    Respir Res. 2025;26:306.
    PubMed     Abstract available
    
    
    October 2025
42. KELSEN SG, Maurer M, Waters M, Dash A, et al
    Safety and tolerability of astegolimab, an anti-ST2 monoclonal antibody: a narrative review.
    Respir Res. 2025;26:302.
    PubMed     Abstract available
    
    
    
43. NOPSOPON T, Cabrera-Perez J, Lee PY, Brodeur KE, et al
    Impact of clinical factors and season on inflammatory cytokines in biologic-treated and untreated asthma.
    Respir Res. 2025;26:291.
    PubMed     Abstract available
    
    
    
44. CHENG WH, Chang WS, Feng PH, Chen KY, et al
    Serine/threonine kinase 33 mediates thrombin-induced interleukin-8 release from human lung epithelial cells in severe asthma.
    Respir Res. 2025;26:288.
    PubMed     Abstract available
    
    
    
45. FOO CT, Langton D, Donovan GM, Thompson BR, et al
    Bronchial thermoplasty reduces ventilation heterogeneity measured by phase-resolved functional lung magnetic resonance imaging in severe asthma.
    Respir Res. 2025;26:290.
    PubMed     Abstract available
    
    
    August 2025
46. YUAN D, Yang X, He B, Han Y, et al
    Yanghe Pingchuan granules inhibit cellular senescence in airway smooth muscle cells to improve bronchial asthma via modulating Nrf2 acetylation.
    Respir Res. 2025;26:266.
    PubMed     Abstract available
    
    
    July 2025
47. KUNTZMAN K, Hakansson KEJ, Ulrik CS, Rastogi D, et al
    Impact of natal and childhood metabolic markers on childhood asthma burden - a nationwide cohort study.
    Respir Res. 2025;26:246.
    PubMed     Abstract available
    
    
    
48. WANG S, Kun T, Tian Z, Huang M, et al
    The MFGE8/integrin beta3 axis mitigates experimental neutrophilic asthma by suppressing NLRP3-Caspase-1 pathway-mediated NETosis.
    Respir Res. 2025;26:229.
    PubMed     Abstract available
    
    
    
49. KHALFAOUI L, Moore RM, Villasboas JC, Whitaker KR, et al
    Spatial phenotyping of human bronchial airways in obstructive lung disease.
    Respir Res. 2025;26:232.
    PubMed     Abstract available
    
    
    
50. DOSANJH DPS, Darrah E, Jensen TJ, Jevnikar Z, et al
    ARTEMISIA: a mechanistic study of a novel Janus kinase 1 inhibitor to advance molecular understanding and precision medicine in asthma.
    Respir Res. 2025;26:233.
    PubMed     Abstract available
    
    
    June 2025
51. WANG D, Liu C, Bao C, Hu J, et al
    Inhibition of the ATP synthase c subunit ameliorates HDM/LPS-induced inflammatory responses in asthmatic bronchial epithelial cells by blocking the mPTP-mtDNA-cGAS-STING axis.
    Respir Res. 2025;26:219.
    PubMed     Abstract available
    
    
    
52. NJOROGE M, Pinheiro GP, Santana CVN, Ali H, et al
    Causes and MEchanisms foR non-atopic Asthma in Children (CAMERA) study: rationale and protocol.
    Respir Res. 2025;26:212.
    PubMed     Abstract available
    
    
    
53. TAYLOR SL, Brooks CR, Elms L, Manning SK, et al
    Sputum quality affects assessment of airway microbiology in childhood asthma.
    Respir Res. 2025;26:209.
    PubMed     Abstract available
    
    
    May 2025
54. ZHAO L, Wu W, Chen G, Huang C, et al
    SERPINB10 promotes macrophage M2 polarization and airway inflammation in asthma.
    Respir Res. 2025;26:181.
    PubMed     Abstract available
    
    
    
55. TIAN J, Zhang Q, Peng M, Guo L, et al
    Exhaled volatile organic compounds as novel biomarkers for early detection of COPD, asthma, and PRISm: a cross-sectional study.
    Respir Res. 2025;26:173.
    PubMed     Abstract available
    
    
    April 2025
56. JIANG H, Jiang Y, Dong R, Fu CY, et al
    ETS2 aggravate allergic airway inflammation by regulating ANT2-mediated cytosolic mitochondrial DsRNA levels.
    Respir Res. 2025;26:159.
    PubMed     Abstract available
    
    
    
57. PINKSTON RI, Schexnayder M, Perveen Z, Langohr IM, et al
    MMP12 deficiency attenuates menthol e-cigarette plus house dust-mite effects on pulmonary iron homeostasis and oxidative stress.
    Respir Res. 2025;26:135.
    PubMed     Abstract available
    
    
    
58. AHN SY, Ho TL, Ko EJ
    Evaluation of the influenza vaccine protection in the house dust mite-induced chronic allergic asthma mice model and the evaluation of squalene oil in water emulsion as an adjuvant candidate.
    Respir Res. 2025;26:132.
    PubMed     Abstract available
    
    
    
59. ZHANG J, Luo W, Cui Y, Sun B, et al
    B-cell epitope peptide immunotherapy alleviates chitin-binding protein-induced type 2 airway inflammation in a Blomia tropicalis-murine model.
    Respir Res. 2025;26:129.
    PubMed     Abstract available
    
    
    
60. CONLEY HE, Davis KU, Adler KB, Lavoie JP, et al
    MARCKS protein is a potential target in a naturally occurring equine model of neutrophilic asthma.
    Respir Res. 2025;26:126.
    PubMed     Abstract available
    
    
    March 2025
61. GOODALL E, Rothnie KJ, Numbere B, Zhang S, et al
    Describing the burden of moderate exacerbations in patients with asthma from the Extended Salford Lung Study (Ext-SLS): a retrospective cohort study.
    Respir Res. 2025;26:121.
    PubMed     Abstract available
    
    
    
62. ADLER A, Bergwik J, Padra M, Papareddy P, et al
    Pharmacological inhibition of MutT homolog 1 (MTH1) in allergic airway inflammation as a novel treatment strategy.
    Respir Res. 2025;26:101.
    PubMed     Abstract available
    
    
    February 2025
63. BERTOLINI F, Carriero VMA, Arrigo E, Guida G, et al
    Vascular remodeling and TSLP/angiogenin overexpression in severe mixed asthma.
    Respir Res. 2025;26:78.
    PubMed     Abstract available
    
    
    
64. WARDEN DE, Zhang H, Jiang Y, Arshad HS, et al
    The role of wheezing subtypes in the development of early childhood asthma.
    Respir Res. 2025;26:79.
    PubMed     Abstract available
    
    
    
65. LIN G, Wei Y, Guo Z, Wang H, et al
    Short- and long-term comparative effectiveness of nirmatrelvir/ritonavir and molnupiravir in asthma patients: a cohort study.
    Respir Res. 2025;26:75.
    PubMed     Abstract available
    
    
    
66. LI N, Xu Y, Xiao X, Ding Z, et al
    Long-term trends in the burden of asthma in China: a joinpoint regression and age-period-cohort analysis based on the GBD 2021.
    Respir Res. 2025;26:56.
    PubMed     Abstract available
    
    
    
67. GUO Y, Zhou Y, Wang R, Lin Y, et al
    YAP as a potential therapeutic target for myofibroblast formation in asthma.
    Respir Res. 2025;26:51.
    PubMed     Abstract available
    
    
    
68. WANG Z, Zhao P, Yan G, Sun A, et al
    Neuropeptide S and its receptor aggravated asthma via TFEB dependent autophagy in bronchial epithelial cells.
    Respir Res. 2025;26:50.
    PubMed     Abstract available
    
    
    
69. LUO T, Ji W, Gong Y, Chen L, et al
    REDD1 mediates HDM-induced nuclear-cytoplasmic translocation and release of IL-33 in airway epithelial cells by downregulating Nrf2.
    Respir Res. 2025;26:47.
    PubMed     Abstract available
    
    
    January 2025
70. DE VOLDER J, Bontinck A, Haelterman V, Boon L, et al
    Anti-IL-5 treatment, but not neutrophil interference, attenuates inflammation in a mixed granulocytic asthma mouse model, elicited by air pollution.
    Respir Res. 2025;26:43.
    PubMed     Abstract available
    
    
    
71. MOORE CM, Thornburg J, Secor EA, Hamlington KL, et al
    Comparative analysis of ambient, in-home, and personal exposures reveals associations between breathing zone pollutant levels and asthma exacerbations in high-risk children.
    Respir Res. 2025;26:40.
    PubMed     Abstract available
    
    
    
72. TIWARI A, Hobbs BD, Sharma R, Li J, et al
    Peripheral blood miRNAs are associated with airflow below threshold in children with asthma.
    Respir Res. 2025;26:38.
    PubMed     Abstract available
    
    
    
73. CHEN X, Shang Y, Shen D, Shi S, et al
    Potential drug targets for asthma identified through mendelian randomization analysis.
    Respir Res. 2025;26:16.
    PubMed     Abstract available
    
    
    
74. PARK HS, Lee J, Kim H, Woo SD, et al
    Comparative analysis of real-world data on the efficacy and safety of and adherence to ICS/LABA combinations in asthma management.
    Respir Res. 2025;26:12.
    PubMed     Abstract available
    
    
    
75. MISIUKIEWICZ-STEPIEN P, Zajusz-Zubek E, Gorska K, Krenke R, et al
    The different response of PM(2.5) stimulated nasal epithelial spheroids in control, asthma and COPD groups.
    Respir Res. 2025;26:8.
    PubMed     Abstract available
    
    
    December 2024
76. FAINARDI V, Grandinetti R, Mussi N, Rossi A, et al
    Exercise-induced bronchoconstriction in children: Delphi study and consensus document about definition and epidemiology, diagnostic work-up, treatment, and follow-up.
    Respir Res. 2024;25:445.
    PubMed     Abstract available
    
    
    
77. TANG H, Li Z, Yang C, Fu L, et al
    CTSS contributes to airway neutrophilic inflammation in mixed granulocytic asthma.
    Respir Res. 2024;25:441.
    PubMed     Abstract available
    
    
    
78. RAO X, Luo H, Luo K, Hu C, et al
    Silencing SMAD4 inhibits inflammation and ferroptosis in asthma by blocking the IL-17A signaling pathway.
    Respir Res. 2024;25:429.
    PubMed     Abstract available
    
    
    November 2024
79. FAN R, Qian H, Xu JY, Wang JY, et al
    Association of asthma and bronchiectasis: Mendelian randomization analyses and observational study.
    Respir Res. 2024;25:413.
    PubMed     Abstract available
    
    
    October 2024
80. AMBHORE NS, Balraj P, Kumar A, Reza MI, et al
    Kiss1 receptor knockout exacerbates airway hyperresponsiveness and remodeling in a mouse model of allergic asthma.
    Respir Res. 2024;25:387.
    PubMed     Abstract available
    
    
    
81. MCDUFFIE EL, Panettieri RA Jr, Scott CP
    Correction to: G(12/13) signaling in asthma.
    Respir Res. 2024;25:371.
    PubMed    
    
    
    
82. LIU Y, Yin Q, Liu B, Lu Z, et al
    Fisetin reduces ovalbumin-triggered airway remodeling by preventing phenotypic switching of airway smooth muscle cells.
    Respir Res. 2024;25:370.
    PubMed     Abstract available
    
    
    
83. GOETEYN E, Taylor SL, Dicker A, Bolle L, et al
    Aggregatibacter is inversely associated with inflammatory mediators in sputa of patients with chronic airway diseases and reduces inflammation in vitro.
    Respir Res. 2024;25:368.
    PubMed     Abstract available
    
    
    
84. CAMINATI M, Vatrella A, Rogliani P, Carpagnano E, et al
    Tezepelumab for severe asthma: elevating current practice to recognize epithelial driven profiles.
    Respir Res. 2024;25:367.
    PubMed     Abstract available
    
    
    September 2024
85. EL ABD A, Dasari H, Dodin P, Trottier H, et al
    Associations between vitamin D status and biomarkers linked with inflammation in patients with asthma: a systematic review and meta-analysis of interventional and observational studies.
    Respir Res. 2024;25:344.
    PubMed     Abstract available
    
    
    
86. BONNESEN B, Eklof J, Biering-Sorensen T, Modin D, et al
    Effect of low climate impact vs. high climate impact inhalers for patients with asthma and COPD-a nationwide cohort analysis.
    Respir Res. 2024;25:339.
    PubMed     Abstract available
    
    
    August 2024
87. ZHANG D, Pu X, Zheng M, Li G, et al
    Employing a synergistic bioinformatics and machine learning framework to elucidate biomarkers associating asthma with pyrimidine metabolism genes.
    Respir Res. 2024;25:327.
    PubMed     Abstract available
    
    
    
88. ALLARD B, Ousova O, Savitskaya Z, Levardon H, et al
    Pulmonary adaptation to repeated poly(I:C) exposure is impaired in asthmatic mice: an observational study.
    Respir Res. 2024;25:314.
    PubMed     Abstract available
    
    
    
89. OUYANG S, Lu P, Li J, Jin H, et al
    Inhaled tea polyphenol-loaded nanoparticles coated with platelet membranes largely attenuate asthmatic inflammation.
    Respir Res. 2024;25:311.
    PubMed     Abstract available
    
    
    
90. GAO F, Lei J, Zhu H, Zhao L, et al
    Small airway dysfunction links asthma exacerbations with asthma control and health-related quality of life.
    Respir Res. 2024;25:306.
    PubMed     Abstract available
    
    
    
91. PATEL A, Buszkiewicz JH, Cook S, Arenberg DA, et al
    Longitudinal association of exclusive and dual use of cigarettes and cigars with asthma exacerbation among US adults: a cohort study.
    Respir Res. 2024;25:305.
    PubMed     Abstract available
    
    
    
92. SUGAWARA H, Saito A, Yokoyama S, Chiba H, et al
    Therapeutic effect of long-acting muscarinic antagonist for treating uncontrolled asthma assessed using impulse oscillometry.
    Respir Res. 2024;25:300.
    PubMed     Abstract available
    
    
    
93. MCDUFFIE EL, Panettieri RA Jr, Scott CP
    G(12/13) signaling in asthma.
    Respir Res. 2024;25:295.
    PubMed     Abstract available
    
    
    July 2024
94. GU W, Huang C, Chen G, Kong W, et al
    The role of extracellular traps released by neutrophils, eosinophils, and macrophages in asthma.
    Respir Res. 2024;25:290.
    PubMed     Abstract available
    
    
    
95. WAN M, Yu Q, Xu F, You LX, et al
    Novel hypoxia-induced HIF-1alphaactivation in asthma pathogenesis.
    Respir Res. 2024;25:287.
    PubMed     Abstract available
    
    
    
96. VINCENT-GALTIE N, Marquant Q, Catherinot E, Ackermann F, et al
    Tezepelumab for refractory eosinophilic granulomatosis with polyangiitis-related asthma.
    Respir Res. 2024;25:272.
    PubMed     Abstract available
    
    
    
97. LIU X, Zhang J, Zhang D, Pan Y, et al
    Necroptosis plays a role in TL1A-induced airway inflammation and barrier damage in asthma.
    Respir Res. 2024;25:271.
    PubMed     Abstract available
    
    
    June 2024
98. ZENG R, Zhang D, Zhang J, Pan Y, et al
    Targeting lysyl oxidase like 2 attenuates OVA-induced airway remodeling partly via the AKT signaling pathway.
    Respir Res. 2024;25:230.
    PubMed     Abstract available
    
    
    May 2024
99. AU-DOUNG PLW, Chan JCH, Kui OYH, Ho MKY, et al
    Objective monitoring tools for improved management of childhood asthma.
    Respir Res. 2024;25:194.
    PubMed     Abstract available
    
    
    April 2024
100. SHARMA E, Lauten K, Zebrak KA, Edwards KC, et al
     Respiratory symptoms and outcomes among cigar smokers: findings from the Population Assessment of Tobacco and Health (PATH) study waves 2-5 (2014-2019).
     Respir Res. 2024;25:185.
     PubMed     Abstract available
     
     
     
101. XIANG J, Liu B, Li Y, Ren Y, et al
     TFEB regulates dendritic cell antigen presentation to modulate immune balance in asthma.
     Respir Res. 2024;25:182.
     PubMed     Abstract available
     
     
     
102. FARINHA I, Heaney LG
     Barriers to clinical remission in severe asthma.
     Respir Res. 2024;25:178.
     PubMed     Abstract available
     
     
     
103. PINKERTON JW, Preite S, Piras A, Zervas D, et al
     PI3Kgammadelta inhibition suppresses key disease features in a rat model of asthma.
     Respir Res. 2024;25:175.
     PubMed     Abstract available
     
     
     
104. WAN R, Srikaram P, Xie S, Chen Q, et al
     PPARgamma attenuates cellular senescence of alveolar macrophages in asthma-COPD overlap.
     Respir Res. 2024;25:174.
     PubMed     Abstract available
     
     
     
105. LIU Y, Chen F, Zeng Z, Lei C, et al
     Neopterin in patients with COPD, asthma, and ACO: association with endothelial and lung functions.
     Respir Res. 2024;25:171.
     PubMed     Abstract available
     
     
     
106. KOVACH MA, Kack U, Che KF, Brundin B, et al
     Systemic IL-26 correlates with improved asthma control in children sensitized to dog allergen.
     Respir Res. 2024;25:163.
     PubMed     Abstract available
     
     
     
107. FUNG NH, Nguyen QA, Owczarek C, Wilson N, et al
     Early-life house dust mite aeroallergen exposure augments cigarette smoke-induced myeloid inflammation and emphysema in mice.
     Respir Res. 2024;25:161.
     PubMed     Abstract available
     
     
     March 2024
108. BERGWIK J, Liu J, Padra M, Bhongir RKV, et al
     A novel quinoline with airway relaxant effects and anti-inflammatory properties.
     Respir Res. 2024;25:146.
     PubMed     Abstract available
     
     
     
109. LU L, Wu F, Peng J, Wu X, et al
     Clinical characterization and outcomes of impulse oscillometry-defined bronchodilator response: an ECOPD cohort-based study.
     Respir Res. 2024;25:149.
     PubMed     Abstract available
     
     
     
110. HSU YT, Wu CC, Wang CC, Sheu CC, et al
     Increased di-(2-ethylhexyl) phthalate exposure poses a differential risk for adult asthma clusters.
     Respir Res. 2024;25:139.
     PubMed     Abstract available
     
     
     
111. MEI S, Li D, Wang A, Zhu G, et al
     The role of sialidase Neu1 in respiratory diseases.
     Respir Res. 2024;25:134.
     PubMed     Abstract available
     
     
     
112. HONG X, Jiang M, Kho AT, Tiwari A, et al
     Circulating miRNAs associate with historical childhood asthma hospitalization in different serum vitamin D groups.
     Respir Res. 2024;25:118.
     PubMed     Abstract available
     
     
     
113. CAI R, Gong X, Li X, Jiang Y, et al
     Dectin-1 aggravates neutrophil inflammation through caspase-11/4-mediated macrophage pyroptosis in asthma.
     Respir Res. 2024;25:119.
     PubMed     Abstract available
     
     
     
114. LAN G, Xie M, Lan J, Huang Z, et al
     Association and mediation between educational attainment and respiratory diseases: a Mendelian randomization study.
     Respir Res. 2024;25:115.
     PubMed     Abstract available
     
     
     February 2024
115. MATERA MG, Rinaldi B, Calabrese C, Belardo C, et al
     The effect of combining an inhaled corticosteroid and a long-acting muscarinic antagonist on human airway epithelial cells in vitro.
     Respir Res. 2024;25:104.
     PubMed     Abstract available
     
     
     
116. SIROUX V, Boudier A, Lyon-Caen S, Quentin J, et al
     Intra-breath changes in respiratory mechanics are sensitive to history of respiratory illness in preschool children: the SEPAGES cohort.
     Respir Res. 2024;25:99.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Asthma is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum